5 Best Small-Cap Growth Stocks to Invest In Now

3. Larimar Therapeutics, Inc. (NASDAQ:LRMR)

Number of Hedge Fund Holders: 31

Larimar Therapeutics, Inc. (NASDAQ:LRMR) is one of the Best Small-Cap Growth Stocks to Invest In Now. Recently, on June 19, Samantha Semenkow, an analyst from Citi, maintained a Buy rating on Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a price target of $14.

​The firm noted that the bullish sentiment is based on the company’s lead drug candidate, Nomlabofusp, which is being developed for Friedreich’s ataxia, a rare genetic disease. The analyst highlighted several upcoming catalysts, including new open-label clinical data and a planned rolling submission to the FDA by June 2026. (Larimar has now submitted the first module of its rolling BLA seeking accelerated approval for nomlabofusp).

​The analyst believes that the drug can help achieve a carrier-like state, where symptoms become minimal or non-existent. Moreover, the firm also expects expanded data covering patients treated for a full year to show continued improvement on key functional measures, while maintaining good safety results.

Larimar Therapeutics, Inc. (NASDAQ:LRMR) develops treatments for rare diseases using its cell-penetrating peptide technology platform.